Study is the largest to explore this potential safety issue to date. Cinacalcet use does not increase the risk for severe gastrointestinal bleeding that leads to hospitalization or death, according to ...

Please provide your email address to receive an email when new articles are posted on . The medical management of mineral and bone disorders in people with end-stage kidney disease on dialysis is ...

Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals with ...

Please provide your email address to receive an email when new articles are posted on . An article suggesting thrice weekly doses of cinacalcet could manage certain aspects of bone and mineral ...

Calciphylaxis bruise Using cinacalcet in combination with other therapies may be even more efficacious, according to results from a new review. Immediate cinacalcet therapy may help improve ...

Learn everything you need to know about Cinacalcet-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Treatment of secondary hyperparathyroidism with vitamin D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular ...

SAN DIEGO, California — Cinacalcet does not reduce the risk for death or major cardiovascular (CV) events among patients with moderate-to-severe secondary hyperparathyroidism who were on hemodialysis.

Cinacalcet (Mimpara: Amgen Ltd) is a calcimimetic agent which increases the sensitivity of calcium-sensing receptors to extracellular calcium ions, thereby inhibiting the release of PTH. It is ...

The systematic review carried out by the Assessment Group identified 7 published reports of randomised controlled trials (RCTs) of cinacalcet versus placebo in people with hyperparathyroidism ...